In vitro binding and signaling profile of the novel mu opioid receptor agonist endomorphin 2 in rat brain membranes

Biochem Biophys Res Commun. 1998 Sep 29;250(3):720-5. doi: 10.1006/bbrc.1998.9395.

Abstract

The recently discovered endogenous mu receptor selective endomorphin 2 was prepared in tritiated form by a catalytic dehalogenation method resulting in a specific radioactivity of 1.98 TBq/mmol (53.4 Ci/mmol), and used for in vitro labelling of rat brain membranes. The binding was saturable, stereospecific and of high affinity (Kd: 0.97 and 1.12 nM based on kinetic and equilibrium binding studies, respectively). The maximal number of binding sites (Bmax) was found to be 114.8 fmol/mg protein. [3H]Endomorphin 2 was displaced by mu-receptor selective specific peptides and heterocyclic compounds with high affinity, whereas kappa and delta receptor specific ligands were much less potent. The Ki values of endomorphin 1 and 2 in inhibiting [3H]naloxone binding increased by 15-fold in the presence of 100 mM NaCl which indicates the agonist property of these peptides. Endomorphins stimulated [35S]GTPgammaS binding and inhibited adenylyl cyclase activity which also provides evidence for the agonist character of endomorphins.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Analgesics, Opioid / pharmacology*
  • Animals
  • Brain / metabolism*
  • Cell Membrane / metabolism*
  • Oligopeptides / pharmacology*
  • Radioligand Assay
  • Rats
  • Rats, Wistar
  • Receptors, Opioid, mu / agonists*
  • Signal Transduction / drug effects*

Substances

  • Analgesics, Opioid
  • Oligopeptides
  • Receptors, Opioid, mu
  • endomorphin 2